Loading clinical trials...
Loading clinical trials...
To evaluate the effect of combined 5-FU and low molecular weight heparin in infusion on the rate of retinal redetachment after silicone oil removal in cases of proliferative vitreoretinopathy (PVR).
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Hamid Ahmadieh, MD
Tehran, Tehran Province, Iran
Start Date
February 1, 2005
Completion Date
July 1, 2007
Last Updated
July 12, 2007
low molecular weight heparin, 5-FU
DRUG
Lead Sponsor
Shahid Beheshti University of Medical Sciences
NCT06541574
NCT04136366
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06166914